Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Literature DB >> 14982812

Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Jean-Baptiste Stern, Philippe Girard, Raffaele Caliandro.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2004 PMID： 14982812 PMCID： PMC353165 DOI： 10.1128/AAC.48.3.1065.2004

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

3 in total

1. Fungal empyema thoracis: an emerging clinical entity.

Authors: S C Ko; K Y Chen; P R Hsueh; K T Luh; P C Yang
Journal: Chest Date: 2000-06 Impact factor: 9.410

2. Antibiotic levels in empyemic pleural fluid.

Authors: L R Teixeira; S A Sasse; M A Villarino; T Nguyen; M E Mulligan; R W Light
Journal: Chest Date: 2000-06 Impact factor: 9.410

Review 3. Voriconazole: a new triazole antifungal agent.

Authors: Margaret M Pearson; P David Rogers; John D Cleary; Stanley W Chapman
Journal: Ann Pharmacother Date: 2003-03 Impact factor: 3.154

3 in total

12 in total

1. Human tissue distribution of voriconazole.

Authors: Stefan Weiler; David Fiegl; Róisín MacFarland; Eva Stienecke; Rosa Bellmann-Weiler; Stefan Dunzendorfer; Michael Joannidis; Romuald Bellmann
Journal: Antimicrob Agents Chemother Date: 2010-11-15 Impact factor: 5.191

2. Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

Authors: J C Poupelin; F Philit; J C Richard; M Badet; S Lemasson; F Bayle; C Guérin
Journal: Intensive Care Med Date: 2006-03-11 Impact factor: 17.440

3. Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Authors: Brad Moriyama; Marisa Ditullio; Eleanor Wilson; Stacey A Henning; Scott R Penzak; Robert L Danner; Gennethel Pennick; Michael G Rinaldi; Adrian M Zelazny; Juan Gea-Banacloche; A John Barrett; Thomas J Walsh
Journal: Antimicrob Agents Chemother Date: 2011-03-14 Impact factor: 5.191

Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

1. Fungal empyema thoracis: an emerging clinical entity.

2. Antibiotic levels in empyemic pleural fluid.

Review 3. Voriconazole: a new triazole antifungal agent.

1. Human tissue distribution of voriconazole.

2. Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

3. Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Review 4. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

5. Anidulafungin Pharmacokinetics in Ascites Fluid and Pleural Effusion of Critically Ill Patients.

Review 6. Voriconazole : a review of its use in the management of invasive fungal infections.

7. Penetration of amphotericin B lipid formulations into pleural effusion.

Review 8. Tissue penetration of antifungal agents.

9. A 19-year-old woman with pleuritic chest pain.

10. Voriconazole in the management of nosocomial invasive fungal infections.